AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
10.64
-0.68 (-6.01%)
At close: Apr 28, 2026, 4:00 PM EDT
10.56
-0.08 (-0.75%)
After-hours: Apr 28, 2026, 4:45 PM EDT
AgomAb Therapeutics NV Analyst Ratings
Total Analysts
3
Consensus Rating
Buy
Price Target
$32.00
Upside
+200.75%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $36 | Buy | Initiates | $36 | +238.35% | Mar 3, 2026 |
| JP Morgan | JP Morgan | Buy Initiates $32 | Buy | Initiates | $32 | +200.75% | Mar 3, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $28 | Buy | Initiates | $28 | +163.16% | Mar 3, 2026 |